Clinical Trials Logo

Low Triiodothyronine Syndrome clinical trials

View clinical trials related to Low Triiodothyronine Syndrome.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05070091 Completed - COVID-19 Clinical Trials

The Impact of Pituitary-thyroid and Pituitary-adrenal Axes Function on COVID-19 Clinical Course.

ENDO-COVID19
Start date: January 26, 2021
Phase:
Study type: Observational

The main focus of the study is the assessment of hormonal function in the course of COVID-19 infection with special regard for trends predicting clinical events defined as primary endpoints of the study.

NCT ID: NCT04112316 Completed - Clinical trials for Heart Failure With Reduced Ejection Fraction

Developing Oral LT3 Therapy for Heart Failure - HFrEF

DOT3HF-HFrEF
Start date: February 11, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Investigation of the safety, feasibility, and preliminary efficacy of thyroid hormone therapy with Liothyronine (LT3) in individuals with heart failure with reduced ejection fraction (HFrEF) and low triiothyronine (T3) syndrome by conducting a randomized, double-blind, placebo-controlled cross-over study with a two week washout period between treatments.

NCT ID: NCT04111536 Completed - Clinical trials for Heart Failure With Preserved Ejection Fraction

Developing Oral LT3 Therapy for Heart Failure - HFpEF

DOT3HF-HFpEF
Start date: March 8, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Investigation of the safety, feasibility, and preliminary efficacy of thyroid hormone therapy with Liothyronine (LT3) in individuals with heart failure with preserved ejection fraction (HFpEF) and low triiodothyronine (T3) syndrome by conducting a randomized, double-blind, placebo-controlled cross-over study with a two-week washout period between treatments.